It will be interesting to see how aggressive the Agency may be in regard to this reminder for Tirzepatide compounding.
All prices were accurate as of April 2026 and are subject to change
Various retrospective studies have pointed to a protective effect of GLP-1 agonists in dementia, with some showing improvements of 40% to 70% compared to other drugs used to treat diabetes, but the new study offers an opportunity to test that hypothesis prospectively
Dawson EB, Evans DR, Harris WA, Teter MC, McGanity WJ
53 The damage to structures such as the hippocampus could be due to silent brain hypoxia as well as an immune response against the virus, which can also affect the blood-brain barrier (BBB)
Some reflect off-label use or member requests shaped by marketing, not medicine